Moderna Says FDA Needs More Time To Assess Its COVID-19 Vaccine For Teens

Bloomberg (10/31, Vizcaino) reports, “Moderna Inc. said it was notified the U.S. Food and Drug Administration will require additional time to assess the company’s emergency request to approve its Covid-19 vaccine for children ages 12 to 17 as regulators e...